Jeffrey Sosman, M.D.
Jeffrey Sosman, M.D., director of the Melanoma Program at Vanderbilt-Ingram Cancer Center, has been chosen to serve as a member of the Cancer Immunopathology and Immunotherapy Study Section with the Center for Scientific Review in the National Institutes of Health (NIH).
As part of the role, Sosman will review grant applications submitted to the NIH and make recommendations to the appropriate advisory council or board.
Members of the study section are chosen based on achievements in their scientific discipline, such as publications in scientific journals, research accomplishments and honors.